Business Wire

Pivot Bio Joins AIM for Climate as Innovation Sprint Partner

Share

Pivot Bio, agriculture’s leading nitrogen innovator, joins the Agriculture Innovation Mission for Climate (AIM for Climate) as an Innovation Sprint Partner, committing at least $291 million in product development funding over four years to accelerate the adoption of climate-resilient microbial nitrogen fertilizers.

Pivot Bio introduced the world’s first nitrogen-producing microbes to U.S. farmers in 2018. Since that time, the company has introduced multiple microbial nitrogen products for wheat, sorghum and other small grains in addition to its flagship product for corn. Farmers have quickly converted their nitrogen management programs to include nitrogen produced by Pivot Bio’s microbes, while reducing their dependence on synthetic nitrogen fertilizer.

“Microbial nitrogen fertilizer has the potential to permanently and immediately deliver reductions in GHG emissions, while delivering co-benefits to watershed health, biodiversity, and farmer margins,” said Karsten Temme, Ph.D., co-founder and CEO of Pivot Bio. “This could be one of the most important technologies for accelerating progress against the world’s 2030 Sustainable Development Goals.”

Adhering to the root of the plants, Pivot Bio’s microbes convert atmospheric nitrogen to a usable source of the critical nutrient throughout a crop’s growing season. These microbes stay with the plant, eliminating the waste associated with fossil fuel-dependent synthetic fertilizers that are applied on top of the ground. Unlike synthetic fertilizers, Pivot Bio’s microbial fertilizer does not leach into waterways nor volatilize into the air, improving air and water quality.

“Farmers are the foundation of the world’s food system and humanity's greatest stewards of our land,” said Temme. “Pivot Bio is committed to partnering with them to deliver better nitrogen while helping to heal the planet.”

Over the next four years, Pivot Bio will continuously improve the nitrogen production capacity of the Company’s microbes and expand into new geographic markets to help more of the world’s farmers nourish their crops with the most climate-friendly and easy-to-use nitrogen on the market.

“As an AIM for Climate Innovation Sprint Partner, we will bring together the best minds and ideas to accelerate our pace of product development and increase farmer access to a dependable and sustainable nitrogen,” said Temme. “We are working toward a world where microbial nitrogen is the main source of crop nutrition and encourage farmers, government leaders and members of the private sector to get in touch to join us in that mission.”

COP27, the United Nations Climate Change Conference, has been called the “food COP,” devoting an entire day, November 12, to agriculture for the first time. Conservative estimates place the total emissions associated with synthetic nitrogen fertilizer at approximately 9 units of CO2eq for every unit of synthetic nitrogen fertilizer produced. Approximately one-third of those emissions are caused by the Haber-Bosch manufacturing process, with direct and indirect emissions of nitrous oxide (N2O) accounting for the rest. Replacing synthetic nitrogen fertilizer with nitrogen-producing microbes avoids these emissions and has the potential to reduce water use (more than 15,000 liters per ton of synthetic N fertilizer) and improve human health outcomes by reducing ozone depletion and particulate generation.

To learn more about Pivot Bio’s innovation sprint, please watch this video message.

About Pivot Bio:
At Pivot Bio, we believe in meeting the needs of the present without compromising the needs of future generations. Our unparalleled understanding of the crop microbiome will help create a future with cleaner water and air. We are dedicated to providing farmers with solutions so they can grow high-quality, environmentally-responsible, and sustainably-focused crops that help feed families worldwide. For more information, visit www.pivotbio.com and follow us on LinkedIn, Twitter, and YouTube.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mitchell Craft
405-473-4553
media@pivotbio.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th

Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release

Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor

Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release

Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not

BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to

I-care Becomes a Unicorn23.12.2025 10:45:00 CET | Press Release

I-care announces the completion of a €20 million fundraising and refinancing operation, carried out as a round reserved for existing shareholders and employees. Based on this operation, the group's valuation reaches €1 billion, making I-care a unicorn. "Becoming a unicorn is a symbolic milestone. To achieve this, we chose to invest before reaping the rewards: we bet on AI when few believed in it, we prioritized R&D, and we built our own production unit. These choices were sometimes difficult, but they were essential to staying ahead of the game. Today, our results confirm that this strategy was the right one," explains Fabrice Brion, CEO of I-care. This fundraising round is the first step in a three-phase development plan. Following the “Eau Rouge” operation in 2022, which enabled I-care to become the world leader in predictive maintenance, the company has now set itself a clear objective: to accelerate its growth in order to increase its market share. The second phase of this plan wil

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye